Almitas Capital’s Metagenomi Therapeutics MGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$299K Buy
+282,308
New +$340K 0.07% 112

Other funds holding MGX

Almitas Capital's MGX Position: Q3 2026 in Review

Almitas Capital opened a new position in Metagenomi Therapeutics (MGX) in Q3 2026: 282,308 shares worth $299K. The stake represents 0.07% of the portfolio and ranks #112 among its holdings.

44 funds tracked by Wall St. Rank hold MGX as of Q3 2026.

  • Almitas Capital held 282,308 shares of Metagenomi Therapeutics worth $299K as of Q3 2026.
  • Metagenomi Therapeutics was a new Almitas Capital position in Q3 2026.
  • Metagenomi Therapeutics made up 0.07% of Almitas Capital's portfolio in Q3 2026, its #112 holding.
  • 44 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q3 2026.

Based on Almitas Capital's 13F filing for Q3 2026, filed 17 Nov 2026.